CSPIA
GSK icon

Cary Street Partners Investment Advisory’s GSK GSK Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.9K Buy
1,887
+162
+9% +$8.57K 0.02% 499
2026
Q1 		$95.2K Sell
1,725
-46
-3% -$2.49K 0.02% 456
2025
Q4 		$86.8K Sell
1,771
-964
-35% -$45K 0.02% 445
2025
Q3 		$118K Buy
2,735
+1,559
+133% +$60.9K 0.05% 341
2025
Q2 		$45.1K Buy
1,176
+162
+16% +$6.19K 0.02% 408
2025
Q1 		$39.3K Buy
1,014
+852
+526% +$31.2K 0.02% 386
2024
Q4 		$5.48K Sell
162
-6,833
-98% -$246K ﹤0.01% 461
2024
Q3 		$286K Sell
6,995
-411
-6% -$16.8K 0.01% 638
2024
Q2 		$285K Buy
7,406
+2,344
+46% +$98.6K 0.01% 612
2024
Q1 		$217K Sell
5,062
-521
-9% -$21.5K 0.01% 651
2023
Q4 		$207K Hold
5,583
– – 0.01% 614
2023
Q3 		$202K Buy
5,583
+803
+17% +$28.5K 0.01% 553
2023
Q2 		$170K Sell
4,780
-160
-3% -$5.74K 0.01% 551
2023
Q1 		$176K Sell
4,940
-442
-8% -$15.5K 0.01% 494
2022
Q4 		$189K Sell
5,382
-847
-14% -$28.2K 0.01% 481
2022
Q3 		$183K Buy
6,229
+1,319
+27% +$50K 0.02% 458
2022
Q2 		$267K Buy
+4,910
New +$271K 0.02% 375
2021
Q1 		– Sell
-8,944
Closed -$411K – 363
2020
Q4 		$411K Buy
8,944
+5,558
+164% +$255K 0.08% 212
2020
Q3 		$159K Buy
+3,386
New +$170K 0.03% 296

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

Cary Street Partners Investment Advisory's GSK Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its GSK (GSK) stake by 9.4% in Q2 2026, buying an estimated $8.57K and bringing the position to 1,887 shares worth $98.9K. The position accounts for 0.02% of the portfolio, ranked #499.

Cary Street Partners Investment Advisory first reported a position in GSK in Q3 2020 and has held it in 19 quarters since. The position peaked at $411K in Q4 2020. 751 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cary Street Partners Investment Advisory held 1,887 shares of GSK worth $98.9K as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 162 GSK shares in Q2 2026, an estimated $8.57K.
  • GSK made up 0.02% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #499 holding.
  • Cary Street Partners Investment Advisory first reported a position in GSK in Q3 2020 and has held it in 19 quarters since.
  • Cary Street Partners Investment Advisory's GSK position peaked at $411K in Q4 2020.
  • 751 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.